Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/21660
Title: Infliximab Dose Escalation as an Effective Strategy for Managing Secondary Loss of Response in Ulcerative Colitis.
Authors: 
Keywords: 
Mesh: 
Issue Date: Oct-2015
Citation: Dig. Dis. Sci..2015 Oct;(60)10:3075-84
Abstract: The outcomes of infliximab dose escalation in ulcerative colitis (UC) have not been well evaluated.
PMID: 26044830
URI: https://hdl.handle.net/20.500.12530/21660
Appears in Collections:Fundaciones e Institutos de Investigación > IIS H. General U. Gregorio Marañón > Artículos
Hospitales > H. U. Infanta Leonor > Artículos
Fundaciones e Institutos de Investigación > IIS H. U. La Princesa > Artículos
Hospitales > H. U. de Fuenlabrada > Artículos
Fundaciones e Institutos de Investigación > IIS H. U. La Paz > Artículos
Fundaciones e Institutos de Investigación > IIS H. U. Clínico San Carlos > Artículos
Hospitales > H. U. Infanta Sofía > Artículos

Files in This Item:
The file with the full text of this item is not available due to copyright restrictions or because there is no digital version. Authors can contact the head of the repository of their center to incorporate the corresponding file.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.